QUOTE AND NEWS
Benzinga  Aug 18  Comment 
Argus maintained its Buy rating on Jacobs Engineering Group Inc (NYSE: JEC), and raised the price target to $60 from $58. The new price target assumes a P/E ratio of 18.2-times next year's earnings, slightly above the historical...
Benzinga  Aug 10  Comment 
UBS cut Jacobs Engineering Group Inc (NYSE: JEC) to Neutral from Buy on valuation, organic growth restrained by lack of customer confidence and near-term uncertainty on an arbitration case. That said, the brokerage acknowledged the company's...
Benzinga  Aug 9  Comment 
  Hecla Mining Company (NYSE: HL) shares gained 4 percent to reach a new 52-week high of $7.05. JP Morgan upgraded Hecla Mining from Neutral to Overweight.. Jacobs Engineering Group Inc (NYSE: JEC) shares reached a new 52-week high of...
newratings.com  Aug 9  Comment 
WASHINGTON (dpa-AFX) - Jacobs Engineering Group Inc. (JEC) revealed a profit for third quarter that dropped compared to the same period last year. The company said its profit came in at $94.83 million, or $0.78 per share. This was down from...
Benzinga  Jul 27  Comment 
Jacobs Engineering Group Inc. (NYSE: JEC) has been granted a contract by Network Rail to continue its support for enhancing rail links from the Great Western main line to Heathrow Airport in the Great Britain. According to the company, the work...
newratings.com  Jun 8  Comment 
WASHINGTON (dpa-AFX) - Shares of Jacobs Engineering (JEC) are seeing notable strength in afternoon trading on Wednesday, with the technical professional services firm currently up by 2.1 percent. With the gain, Jacobs has reached its best intraday...




 

Jacobs Engineering Group (NYSE: JEC) designs and builds refineries, pharmaceutical manufacturing and chemical plants and other types of technically sophisticated facilities for its clients. For instance, the company is responsible for designing all aspects (power/steam generation, underground infrastructure, and tank farm) of a bitumen-collection facility in the oil sands of Fort Hill, Canada. In addition to facility design, the company provides both engineering and consulting services. In its role as NASA's primary services support contractor, the company helps design, test, and analyze space-and aircraft components.

Rising demand for oil has benefited the company in over the last few years. Although the company serves a number of different industries, its biggest source of revenue are refiners and oil exploration and production companies, which the company helps with expanding existing refineries and extracting more oil from existing wells. As oil prices rises, demand for JEC's services also increases.

Business Overview

Business & Financial Metrics[1]

In 2009, JEC generated a net income of $399.9 million on revenues of $11.47 billion. This represents a 5.0% decrease in net income and a 1.9% increase in total revenue from 2008, when the company earned $420.7 million on $11.25 billion in revenue.

Business Segments[2]

Jacobs has only one reportable segment but breaks down its revenue in terms of geographic region. Well over half of the company's revenues come from customers in the United States.

IMAGE:JEC-Geo2009.jpg[2]

Trends and Forces

US Government Spending Impacts JEC less than competitors

Contracts with the United States government--principally through the Department of Defense (DOD), the Department of Energy (DOE), and the Department of Transportation (DOT)--accounted for 20.3% of Jacobs' total revenues in 2009.[3] While this exposure is less than some of Jacobs' competitors it still represents a significant portion of the company's total yearly services and puts the company at risk of volatility in government spending. The US budget varies heavily from year to year depending on tax revenues, the party in power, military realities, and public's perception of the social worth of any given project. This volatility has the potential to impact Jacob's future revenues, either through adjustments in the number of new contracts awarded or the extent to which old contracts are completely funded and expanded upon.

The Continued Profitability of Name-Brand Prescription Drugs Essential for Jacobs' Pharmaceutical Projects

While Jacobs' relatively small client base can be beneficial, it can also prove troublesome in shifting markets. This would quickly become apparent in the company's projects for the Pharmaceutical industry if new name-brand prescription drugs lost their traditional profitability. Through the 2000's the price of prescription drugs rose steadily, prompting many politicians to consider measures limiting prices or shortening the length of patent protection on these drugs. Any measure of this type would inevitably reduce the profitability of new drugs coming to market, and this would have a dampening effect on development and production efforts on the part of the name-brand drug manufacturers. In 2009, Jacobs received nearly 10% of total revenues from projects for the pharmaceutical and biotechnology industries for services ranging from construction of new labs and plants to maintenance of production facilities.[4] Any spending cuts on these types of projects would have a significant negative impact on Jacobs' earnings. While government price-capping actions would have a positive effect on the generic drug market, Jacobs' ties to the major manufacturers would prevent it from quickly capitalizing on this growth.


Competition

Competitors by Primary Service Market

Jacobs breaks its competitive markets down into four categories: a broad market: Engineering, Construction, and Maintenance (ECM); and then more specific Buildings; Infrastructure; and U.S. Federal Programs.

References

  1. JEC 2009 10-K pg. F-4  
  2. 2.0 2.1 JEC 2009 10-K pg. F-29  
  3. JEC 2009 10-K pg. 21  
  4. JEC 2009 10-K pg. 37  
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki